Active	Status	Sponsor type	Region	Phase	Filter
6 Active 0 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Delgado, Vanessa
SARO.20.002, NCT05011305: Saroglitazar Magnesium for the Treatment of Nonalcoholic Steatohepatitis with Fibrosis	Active, not recruiting	2	180	US, RoW	Saroglitazar Magnesium 2 mg, Investigational Product, Saroglitazar Magnesium 4 mg, Placebo, Comparator Agent	Zydus Therapeutics Inc.	Nonalcoholic Steatohepatitis, Fibrosis	07/25	07/25
NCT03617263: Saroglitazar Magnesium 4 Mg in the Treatment of NAFLD in Women with PCOS (EVIDENCES VII)	Active, not recruiting	2	60	US, RoW	Saroglitazar Magnesium 4 mg Tablet, Not any, Placebo	Zydus Therapeutics Inc.	Non-alcoholic Fatty Liver Disease in Women with PCOS	11/24	11/24
Vanessa
SARO.20.002, NCT05011305: Saroglitazar Magnesium for the Treatment of Nonalcoholic Steatohepatitis with Fibrosis	Active, not recruiting	2	180	US, RoW	Saroglitazar Magnesium 2 mg, Investigational Product, Saroglitazar Magnesium 4 mg, Placebo, Comparator Agent	Zydus Therapeutics Inc.	Nonalcoholic Steatohepatitis, Fibrosis	07/25	07/25
NCT04304911: UP in Blended Format for Transdiagnostic Treatment of Emotional Disorders in the Spanish National Health System	Recruiting	N/A	92	Europe	Blended intervention (UP-APP), Cognitive Behavioral Therapy (TAU)	Instituto de Investigación Sanitaria Aragón	Emotional Disorder, Anxiety Disorders, Depressive Disorder	03/24	06/25
Tan, Vicki
SARO.20.002, NCT05011305: Saroglitazar Magnesium for the Treatment of Nonalcoholic Steatohepatitis with Fibrosis	Active, not recruiting	2	180	US, RoW	Saroglitazar Magnesium 2 mg, Investigational Product, Saroglitazar Magnesium 4 mg, Placebo, Comparator Agent	Zydus Therapeutics Inc.	Nonalcoholic Steatohepatitis, Fibrosis	07/25	07/25
ARGONAUT, NCT04638751: Stool and Blood Sample Bank for Cancer Patients	Recruiting	N/A	5000	US	Immunotherapy, Chemotherapy, CRC surgical resection, Colonoscopy	Persephone Biosciences	Non-small Cell Lung Cancer, Colorectal Cancer, Triple Negative Breast Cancer, Pancreas Cancer	12/24	12/25